DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...
Researchers are trialling the use of cell therapy used in cancer treatment, in the hope it could offer a possible cure for those with the illness. | ITV National News ...
A replay of the webcast will be available for 90 days and can be accessed by visiting the “Investor Calendar” section of the Vera Therapeutics website.
In a society where acceptance remains elusive for many, the Special Children Center Group Home Texas stands as a crucial lifeline for transgender youths and adults. This initiative doesn't just ...
ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.